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Foreword
As the largest organ of the body, the skin performs multiple critical functions, such as 
serving as the primary barrier to the external environment. For this reason, the skin is 
often exposed to potentially hazardous agents, including chemicals, which may contribute 
to the onset of a spectrum of adverse health effects ranging from localized damage (e.g., 
irritant contact dermatitis and corrosion) to induction of immune-mediated responses 
(e.g., allergic contact dermatitis and pulmonary responses), or systemic toxicity (e.g., 
neurotoxicity and hepatoxicity). Understanding the hazards related to skin contact with 
chemicals is a critical component of modern occupational safety and health programs.
In 2009, the National Institute for Occupational Safety and Health (NIOSH) pub-
lished Current Intelligence Bulletin (CIB) 61: A Strategy for Assigning New NIOSH Skin 
Notations [NIOSH 2009–147]. This document provides the scientific rationale and 
framework for the assignment of multiple hazard-specific skin notations (SK) that 
clearly distinguish between the systemic effects, direct (localized) effects, and immune- 
mediated responses caused by skin contact with chemicals. The key step within assign-
ment of the hazard-specific SK is the determination of a substance’s hazard potential, or 
its potential for causing adverse health effects as a result of skin exposure. This determi-
nation entails a health hazard identification process that involves use of the following:
 • Scientific data on the physicochemical properties of a chemical
 • Data on human exposures and health effects
 • Empirical data from in vivo and in vitro laboratory testing
 • Computational techniques, including predictive algorithms and mathematical 
models that describe a selected process (e.g., skin permeation) by means of ana-
lytical or numerical methods. 
This Skin Notation Profile provides the SK assignment and supportive data for sodium 
hydroxide (NaOH; CAS No. 1310–73–2). In particular, this document evaluates and 
summarizes the literature describing the substance’s hazard potential and its assess-
ment according to the scientific rationale and framework outlined in CIB 61. In meet-
ing this objective, this Skin Notation Profile intends to inform the audience—mostly 
occupational health practitioners, researchers, policy- and decision-makers, employers, 
and workers in potentially hazardous workplaces—so that improved risk-management 
practices may be developed to better protect workers from the risks of skin contact with 
the chemical of interest.
John Howard, M.D. 
Director, National Institute for  
   Occupational Safety and Health 
Centers for Disease Control and Prevention
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Abbreviations
ACGIH American Conference of Governmental Industrial Hygienists
ATSDR Agency for Toxic Substances and Disease Registry
CIB Current Intelligence Bulletin
(COR) (COR) subnotation of SK: DIR indicating the potential for a chemical 
   to be corrosive following exposure of the skin
DIR skin notation indicating the potential for direct effects to the skin 
   following contact with a chemical
EC European Commission
GHS Globally Harmonized System of Classification and Labeling of Chemicals
IARC International Agency for Research on Cancer
in2  inches
LD50  dose resulting in 50% mortality in the exposed population
LDLo dermal lethal dose





NIOSH National Institute for Occupational Safety and Health
NTP National Toxicology Program
OEL occupational exposure limit
OSHA Occupational Safety and Health Administration
SEN skin notation indicating the potential for immune-mediated reactions 
   following exposure of the skin
SK skin notation
SYS skin notation indicating the potential for systemic toxicity following 
   exposure of the skin
USEPA United States Environmental Protection Agency
μg/cm2  microgram(s) per square centimeter
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Glossary 
Absorption—The transport of a chemical from the outer surface of the skin into both 
the skin and systemic circulation (including penetration, permeation, and resorption).
Acute exposure—Contact with a chemical that occurs once or for only a short period 
of time.
Cancer—Any one of a group of diseases that occurs when cells in the body become 
abnormal and grow or multiply out of control.
Contaminant—A chemical that is (1) unintentionally present within a neat substance 
or mixture at a concentration less than 1.0% or (2) recognized as a potential carcinogen 
and present within a neat substance or mixture at a concentration less than 0.1%.
Cutaneous (or percutaneous)—Referring to the skin (or through the skin).
Dermal—Referring to the skin.
Dermal contact—Contact with (touching) the skin.
Direct effects—Localized, non-immune-mediated adverse health effects on the skin, 
including corrosion, primary irritation, changes in skin pigmentation, and reduction/
disruption of the skin barrier integrity, occurring at or near the point of contact with 
chemicals.
Immune-mediated responses—Responses mediated by the immune system, including 
allergic responses. 
Sensitization—A specific immune-mediated response that develops following expo-
sure to a chemical, which, upon re-exposure, can lead to allergic contact dermatitis 
(ACD) or other immune-mediated diseases such as asthma, depending on the site and 
route of re-exposure. 
Substance—A chemical. 
Systemic effects—Systemic toxicity associated with skin absorption of chemicals after 
exposure of the skin.
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This Skin Notation Profile presents (1) a brief 
summary of technical data associated with 
skin contact with NaOH and (2) the ratio-
nale behind the hazard-specific skin notation 
(SK) assignment for NaOH. The SK assign-
ment is based on the scientific rationale and 
logic outlined in the Current Intelligence Bul-
letin (CIB) 61: A Strategy for Assigning New 
NIOSH Skin Notations [NIOSH 2009]. 
The summarized information and health 
hazard assessment are limited to an evalu-
ation of the potential health effects of der-
mal exposure to NaOH. A literature search 
was conducted through July 2010 to identify 
information on NaOH, including but not 
limited to data relating to its toxicokinetics, 
acute toxicity, repeated-dose systemic toxic-
ity, carcinogenicity, biological system/func-
tion–specific effects (including reproductive 
and developmental effects and immunotox-
icity), irritation, and sensitization. Informa-
tion was considered from studies of humans, 
animals, or appropriate modeling systems 
that are relevant to assessing the effects of 
dermal exposure to NaOH. 
1.3  Overview of SK Assignment 
for NaOH
NaOH is potentially capable of acting as 
a corrosive agent following skin contact. A 
critical review of available data has resulted 
in the following SK assignment for NaOH: 
SK: DIR (COR). Table 1 provides an over-
view of the critical effects and data used to 
develop the SK assignment for NaOH.
2 Systemic Toxicity from Skin 
Exposure (SK: SYS)
No toxicokinetic data from human, in 
vivo, or in vitro studies investigating der-
mal exposure to NaOH were identified. 
No systemic effects of dermal exposure 
in humans or animals have been report-
ed. No estimated values for dermal lethal 
dose (LDLo) in humans or dermal LD50 
(the dose resulting in 50% mortality in 
the exposed population) in animals have 
1 Introduction
1.1 General Substance Information
Chemical: Sodium hydroxide (NaOH)
CAS No: 1310–73–2
Synonyms:
NaOH; Caustic Soda: Lye; Soda 
Lye; Sodium Hydrate





Sodium hydroxide (NaOH) is used 
to manufacture soaps, rayon, paper, 
explosives, dyestuffs, and petroleum 
products. It is also used in processing 
cotton fabric, laundering and bleach-
ing, metal cleaning and processing, 
oxide coating, electroplating, and elec-
trolytic extracting [ATSDR 2002]. 






) been identified. No epidemiological, occu-pational exposure, animal, or repeat-dose 
toxicity studies evaluating the potential of 
NaOH to cause systemic effects following 
dermal exposure were identified. However, 
because of the physicochemical properties 
of the substance, repeated applications to 
the skin are likely to produce increasing 
damage to the skin prior to systemic ef-
fects being observed. It is unlikely that 
exposures to nonirritating concentrations 
would increase the concentration of sodi-
um in the blood or increase the pH of the 
blood to a significant degree. Thus, under 
nonirritating exposure conditions, NaOH 
can be considered not systemically toxic.
The literature search revealed no standard 
toxicity or specialty studies evaluating bio-
logical system/function–specific effects (in-
cluding reproductive and developmental ef-
fects and immunotoxicity) following dermal 
exposure to NaOH. No studies evaluating 
the carcinogenicity of NaOH following 
dermal exposure were identified. Table 2 
provides a summary of carcinogenic des-
ignations from multiple governmental and 
nongovernmental organizations for NaOH.
No reliable data were identified upon 
which to evaluate the potential for NaOH 
to be absorbed through the skin or con-
tribute to the onset of systemic toxic ef-
fects following dermal exposure to the 
substance. Therefore, on the basis of the 
data for this assessment, NaOH is not as-
signed the SK: SYS notation.
3 Direct Effects on Skin (SK: DIR)
The direct skin effects of NaOH are caused 
by its strong alkalinity. NaOH solutions 
with a pH of 11.5 or greater should be 
considered corrosive to the skin [NIOSH 
2009]. A 0.1-molar concentration (molar-
ity; M) or 1% aqueous solution of NaOH 
has a pH of about 13 [Pierce 1993]. The M 
(the number of moles of a given substance 
per liter of solution) of NaOH associated 
with a pH of 11.5 is approximately 0.003 
M, and concentrations equal to or greater 
than this are considered corrosive to the 
skin [NIOSH 2009]. Less concentrated 
solutions of NaOH, although not cor-
rosive, can be irritating to the skin. The 
concentration-dependent corrosivity of 
NaOH has been demonstrated in a num-
ber of volunteer studies, dermal applica-
tion tests in animals, and in vitro tests for 
corrosivity in human or animal skin mod-
els or of skin integrity in cadaver skin.
Reports are available from several studies of 
the impact of various NaOH concentrations 
and exposure durations on the skin of vol-
unteers and in animal toxicity tests. Nagao 
et al. [1972] noted total destruction of the 
epidermis in 60 minutes in skin biopsies of 
volunteers who had 1-normal (N)* NaOH 
Table 1. Summary of the SK assignment for NaOH
Skin notation Critical effect Data available
SK: DIR (COR) Skin corrosion Sufficient human and animal data
*The document retains the unit of concentration of applied sodium hydroxide (NaOH) as “normality” as re-
ported by the study authors. “Normality” refers to the activity of a reagent: how many moles of active species 
(H+ or OH- ions) are there per liter?  A normal (N) solution of a base, such as NaOH, is the number of 
moles of OH- ions produced per liter. A 1-N NaOH solution produces 1 mole of OH- ions and can react 
with 1 mole of an acid. For NaOH or hydrochloric acid (HCl), the normality is equal to the molarity. For 
NaOH, to convert from normality to percent solution, multiply the normality by the formula weight (FW 
[the mass of 1 mole of a compound] = 40.0) and divide by 10; that is, % solution = normality × 40.0 × 1/10.







applied to their forearms for 15 to 180 min-
utes. A study conducted by Seidenari et al. 
[1995], involving a 24-hour patch test in 
34 volunteers, showed that a 4% aqueous 
NaOH solution caused an enhanced inflam-
matory response with pronounced barrier 
function damage. Agner and Serup [1987] 
reported that a 2% aqueous solution of 
NaOH applied to the skin of volunteers un-
der occlusion for 1 hour caused severe crust-
ing in some volunteers but no inflammation 
in others up to 96 hours post-application. 
These results suggest significant variability 
in the corrosivity of NaOH to human skin 
and verify that concentrations at or above 1 
N are corrosive. In a primary skin irritation 
test, 5% to 30% aqueous solutions of NaOH 
were corrosive to rabbit skin [United States 
Testing Company 1976]. A study con-
ducted by Srikrishna and Monteiro-Riviere 
[1991] reported that 2-N and 4-N NaOH 
caused severe necrosis in all epidermal lay-
ers, whereas 6-N NaOH caused numerous 
and severe blisters, with necrosis extending 
deeper into the subcutaneous tissue, when 
applied on the lower abdominal region 
of weanling pigs. A 50% NaOH solution 
caused a burn that was rapid and progres-
sive in both depth and extent when applied 
to 2 square inches (in2) of the clipped backs 
of mice [Bromberg et al. 1965]. NaOH was 
found to be irritating to pig skin examined 
immediately after application of 1-N aque-
ous NaOH, as evidenced by the presence of 
vesicular nuclei and increased eosinophilia 
and a fine, dense cross-striation in polarized 
light [Karlsmark et al. 1988]. In rabbits, 
4-hour exposure to a 2% NaOH solution 
caused skin corrosion, whereas a 1% solu-
tion caused no damage [Vernot et al. 1977]. 
The corrosivity of NaOH has also been 
demonstrated in a variety of in vitro assays. 
An aqueous solution of NaOH at pH 13.5 
was corrosive in an in vitro Corrositex assay, 
with an average break-through time of 13 
minutes [Stobbe et al. 2003]. Perkins et al. 
[1996] concluded that a 10% NaOH solu-
tion was corrosive to the skin, on the basis 
of cytotoxicity in human-skin-equivalent 
cultures. In another in vitro study, using iso-
lated perfused porcine skin flaps, Srikrishna 
and Monteiro-Riviere [1991] reported that 
4-N and 6-N NaOH caused severe necrosis 
of all epidermal cell layers and dermis after 
8 hours of topical perfusion.
The concentration of NaOH that was 
demonstrated to be corrosive to the skin 
varied according to the test system em-
ployed and the duration of exposure. A 
Table 2. Summary of the carcinogenic designations* for NaOH by  
numerous governmental and nongovernmental organizations







Abbreviations: ACGIH = American Conference of Governmental Industrial Hygienists; EC = European Commission, Joint Re-
search, Institute for Health and Consumer Protection; IARC = International Agency for Research on Cancer; NIOSH = National 
Institute for Occupational Safety and Health; NTP = National Toxicology Program; USEPA = United States Environmental 
Protection Agency.
*Note: The listed cancer designations were based on data from nondermal (such as oral or inhalation) exposure rather than der-
mal exposure.







number of the available studies demon-
strate more limited irritant responses. For 
example, in a patch test conducted in two 
different laboratories, in which a 0.5% so-
lution (0.2 milliliter [mL]) was applied 
for progressively longer durations of 0.5, 
1, 2, 3, and 4 hours to the skin of volun-
teers (treatment sites were moved for each 
patch application), NaOH was judged to 
be irritating to the skin; half of the vol-
unteers had a reaction after just 1 hour of 
application [Griffiths et al. 1997]. This re-
action was so vigorous that exposure for 
a greater duration was not undertaken at 
any site. Irritant contact dermatitis was 
also reported in volunteers after single 
(24-hour) or repeated (5-day) applica-
tion of NaOH concentrations of 0.125% 
to 1.0% in aqueous medium [Park and 
Eun 1995]. Willis et al. [1988] reported 
that the 2% concentration of NaOH 
produced mild to moderate irritation for 
75% of the 42 male volunteers, under the 
patch-testing conditions (1%, 2%, or 4% 
NaOH; closed; 48 hours). Animal studies 
also have identified irritant concentrations 
of NaOH in the absence of corrosivity. 
In a patch test a well-defined erythema 
with slight thickness of skin was observed 
when 2% NaOH solution in 1-propanol 
was applied to the shaved back of mice 
for 24 hours, whereas a 1% solution did 
not cause any reaction [Li et al. 1998]. An 
in vitro study conducted by Bartnik et al. 
[1990] indicated that NaOH dissolved in 
aqueous medium, applied at a dose of 500 
to 5000 micrograms per square centimeter 
(μg/cm2) to the skin explants of hairless 
mice, caused moderate to strong irritation; 
this was determined on the basis of the 
membrane-damaging effects, as assessed 
by lactate dehydrogenase and glutamic-
oxalacetate transaminase activities.
The available data demonstrate that NaOH 
of sufficient concentration is corrosive to 
the skin, as shown by the physicochemical 
properties of NaOH solutions, by tests for 
irritation or corrosivity in vivo in volunteers 
[Nagao et al. 1972; Agner and Serup 1987; 
Seidenari et al. 1995†] and experimental 
animals [Bromberg et al. 1965; United 
States Testing Company Inc. 1976; Ver-
not et al. 1977; Srikrishna and Monteiro-
Riviere 1991], and by studies of human 
and animal in vitro systems [Srikrishna 
and Monteiro-Riviere 1991; Perkins et al. 
1996; Stobbe et al. 2003]. It appears that 
more dilute solutions (for example, 0.5% 
or less) may be irritating to the skin. The 
transition point between corrosivity and 
irritation also is a function of duration of 
skin contact. NaOH solutions with a pH 
at or above 11.5 are considered corrosive 
[NIOSH 2009]. Therefore, on the basis of 
the data for this assessment, NaOH is as-
signed the SK: DIR (COR) notation.
4 Immune-mediated 
Responses (SK: SEN)
One study investigating the skin sensiti-
zation potential of NaOH in humans was 
identified. Park and Eun [1995] applied 
diluted NaOH solutions ranging from 
0.125% to 1.0% to the backs of male volun-
teers. After 7 days, a challenge test was ad-
ministered with a 0.125% NaOH solution. 
The authors reported that the observed irri-
tation corresponded with the concentration 
of NaOH, but an increased response was 
not observed when the previously patch-
tested sites were rechallenged. Park and 
Eun [1995] concluded that NaOH sodium 
hydroxide did not elicit an immune-medi-
ated response and does not have a potential 
to act as a skin sensitization. No predic-
tive tests on animals (for example, guinea 
pig maximization tests, Buehler tests, or 
†References in bold text indicate studies that served 
as the basis of the SK assignment.







murine local lymph node assays) or any 
other studies that evaluated the potential 
of the substance to cause skin sensitization 
were identified. Therefore, on the basis of 
the data for this assessment, NaOH is not 
assigned the SK: SEN notation.
5 Summary
No reliable data were identified to assess 
the potential for absorption through the 
skin or systemic toxicity following dermal 
exposure to NaOH. Mathematical mod-
eling predicts NaOH can be absorbed 
through the skin, but repeated applica-
tions of NaOH are more likely to produce 
skin damage prior to eliciting systemic 
effects. It is unlikely that repeated appli-
cation of nonirritating concentrations of 
NaOH can produce systemic effects, given 
that such exposures would not significant-
ly increase the concentration of sodium in 
the blood or increase the pH of the blood. 
The weight of evidence on the physico-
chemical properties of NaOH solutions, 
from several in vivo irritation or corrosiv-
ity tests involving volunteers [Nagao et 
al. 1972; Agner and Serup 1987; Seide-
nari et al. 1995] and experimental animals 
[Bromberg et al. 1965; United States 
Testing Company 1976; Vernot et al. 
1977; Srikrishna and Monteiro-Riviere 
1991], and from human and animal in 
vitro systems [Srikrishna and Monteiro-
Riviere 1991; Perkins et al. 1996; Stobbe 
et al. 2003] demonstrates that NaOH of 
sufficient concentration is corrosive to the 
skin. NaOH solutions with a pH of 11.5 
or greater should be considered corrosive 
to the skin [NIOSH 2009]. Despite the 
wide application of NaOH in occupation-
al settings, the literature search yielded no 
reports on occupational cases, diagnostic 
patch tests in humans, or predictive tests 
in animals that involved the potential of 
NaOH to cause skin sensitization. There-
fore, on the basis of these assessments, 
NaOH is assigned a composite skin nota-
tion of SK: DIR (COR). 
Table 3 summarizes the skin hazard des-
ignations for NaOH previously issued 
by NIOSH and other organizations. 
The equivalent dermal designations for 
NaOH, according to the Global Harmo-
nization System (GHS) of Classification 
and Labelling of Chemicals, is Skin Cor-
rosion Category 1A (Hazard statement: 
Causes severe skin burns and eye damage) 
[European Parliament 2008]. 
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